Wednesday, December 28, 2022 1:07:38 AM
No problem. I started a small position about two years ago and have been adding ever since. I considered it once-in-a-life opportunity. Had to do so by reducing significantly another ticker that I was once all in. I don't worry about the RA at all. LP had strategic move by filing for approval in Britain since Novocure was not approved in Britain and there is hugely unmet need in that country. Did you recall Dr. Ashkan once said something to the effect that FDA is being too political? So it is definitely a smart move to start with Britain.
I don't worry about the court case either. Had the seven MMs ever dreamed that NWBO, a company that lives on loan, would sue all seven of them together before NWBO really filed the lawsuit? Never in a million years. I would think that NWBO must have something unequivocal to prove its case otherwise this would be a suicidal act. Prolonged law suit can drain NWBO very limited financial resources. As I said before, in the end it might just take a couple of whistleblowers to wrap up the case. It is my speculation.
I don't worry about the court case either. Had the seven MMs ever dreamed that NWBO, a company that lives on loan, would sue all seven of them together before NWBO really filed the lawsuit? Never in a million years. I would think that NWBO must have something unequivocal to prove its case otherwise this would be a suicidal act. Prolonged law suit can drain NWBO very limited financial resources. As I said before, in the end it might just take a couple of whistleblowers to wrap up the case. It is my speculation.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
